查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1753929

2025 年至 2033 年内视镜逆行性胰胆管摄影市场报告（按产品、程序、最终用户和地区）

Endoscopic Retrograde Cholangiopancreatography Market Report by Product, Procedure, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球内视镜逆行性胰胆管摄影市场规模达 17 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 28 亿美元，2025-2033 年期间的成长率 (CAGR) 为 5.58%。

内视镜逆行性胰胆管摄影 (ERCP) 是一种用于诊断和治疗肝臟、胆囊、胆管和胰臟异常的影像学技术。它结合了 X 光和一根细长、灵活、轻巧的内视镜导管，穿过食道、口腔和胃部。它有助于检测胆管中的阻塞、结石、感染和肿瘤，以及胰管中的液体渗漏。此外，与开放性手术相比，ERCP 的侵入性较小，能够提供更详细、更准确的胰胆系统资讯。因此，全球范围内对用于检查吞嚥困难、腹泻、体重减轻、胃灼热和便血等症状的内视镜治疗设备的需求正在不断增长。

内视镜逆行性胰胆管摄影市场趋势：

全球人口不断增长，各种慢性胃肠道 (GI) 和慢性胆道疾病（包括巴雷特病、胆道疾病、肝病、克隆氏症、发炎性肠道疾病、消化性溃疡以及胃食道逆流症 (GERD)）的盛行率不断上升，是积极影响市场的关键因素之一。此外，良性胰臟和肝臟肿瘤的发生率不断上升，尤其是在老年族群中，以及全球癌症发生率的不断上升，正在推动市场发展。同时，医院和诊断中心的扩张也增加了对影像技术的需求，从而推动了市场成长。此外，各国政府和医疗机构加强对先进内视镜设备和改善内视镜研究的投资，也正在增强市场成长。此外，消费者为了快速康復和减少疼痛而越来越倾向于微创手术，以及人们对括约肌切开器等 ERCP 设备的认知度不断提高，这些都为市场前景带来了良好的预期。此外，医疗保健基础设施的持续改善和医疗旅游业的大幅成长预计将推动市场成长。

本报告回答的关键问题

  • 全球内视镜逆行性胰胆管摄影市场有多大？ 2025-2033年全球内视镜逆行性胰胆管摄影市场的预期成长率为何？
  • 推动全球内视镜逆行性胰胆管摄影市场发展的关键因素有哪些？
  • COVID-19 对全球内视镜逆行性胰胆管摄影市场有何影响？
  • 根据产品，全球内视镜逆行性胰胆管摄影市场是如何分布的？
  • 根据手术程序，全球内视镜逆行性胰胆管摄影市场如何分布？
  • 根据最终用户，全球内视镜逆行性胰胆管摄影市场是如何分布的？
  • 全球内视镜逆行性胰胆管摄影市场的主要区域有哪些？
  • 全球内视镜逆行性胰胆管摄影市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球内视镜逆行性胰胆管摄影市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 内视镜
  • 内视镜治疗设备
    • 关键部分
      • 括约肌切开器
      • 碎石机
      • 支架
      • 其他的
  • 可视化系统
  • 能源设备
  • 其他的

第七章：市场区隔：依程序

  • 胆道括约肌切开术
  • 胆道支架置入术
  • 胆道扩张
  • 胰臟括约肌切开术
  • 胰管支架置入术
  • 胰管扩张

第八章：市场区隔：按最终用户

  • 医院和诊所
  • 门诊手术中心
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boston Scientific Corporation
    • CONMED Corporation
    • Cook Group Incorporated
    • Fujifilm Holdings Corporation
    • Hobbs Medical Inc.
    • Johnson & Johnson
    • Medi-Globe GmbH
    • Medtronic plc
    • Olympus Corporation
    • Shaili Endoscopy
    • Steris Corporation
    • Telemed Systems Inc.
Product Code: SR112025A6442

The global endoscopic retrograde cholangiopancreatography market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.58% during 2025-2033.

Endoscopic retrograde cholangiopancreatography (ERCP) is an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, and pancreas. It combines X-rays and a long, flexible, lightweight endoscope tube that passes through the esophagus, mouth, and stomach. It helps detect blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct. Besides this, it is a less invasive procedure than open surgery and provides more detailed and accurate information about the pancreaticobiliary system. As a result, the demand for endotherapy devices is increasing across the globe to investigate dysphagia, diarrhea, weight loss, heartburn, and stool blood.

Endoscopic Retrograde Cholangiopancreatography Market Trends:

The growing global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett's disease, biliary, liver, Crohn's, inflammatory bowel, and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), represent one of the key factors positively influencing the market. In addition, the increasing occurrence of benign pancreas and liver tumors, especially among the geriatric population, along with the growing occurrence of cancer across the globe, is driving the market. In line with this, the expansion of hospitals and diagnostic centers is increasing the need for imaging techniques propelling the market growth. Furthermore, rising investments by governments and healthcare organizations of various countries in advanced endoscopy devices and improve endoscopy research is strengthening the market growth. Apart from this, the shifting consumer preference toward minimally invasive surgeries for a speedy recovery and minimal pain and rising awareness about ERCP devices like sphincterotomes are offering a favorable market outlook. Moreover, continuous improvements in healthcare infrastructure and a considerable rise in medical tourism are expected to propel market growth.

Key Market Segmentation:

Breakup by Product:

  • Endoscope
  • Endotherapy Devices
    • Sphincterotomes
    • Lithotripter
    • Stents
    • Others
  • Visualization Systems
  • Energy Devices
  • Others

Breakup by Procedure:

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilatation

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.

Key Questions Answered in This Report

  • 1.How big is the global endoscopic retrograde cholangiopancreatography market?
  • 2.What is the expected growth rate of the global endoscopic retrograde cholangiopancreatography market during 2025-2033?
  • 3.What are the key factors driving the global endoscopic retrograde cholangiopancreatography market?
  • 4.What has been the impact of COVID-19 on the global endoscopic retrograde cholangiopancreatography market?
  • 5.What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the product?
  • 6.What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the procedure?
  • 7.What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the end user?
  • 8.What are the key regions in the global endoscopic retrograde cholangiopancreatography market?
  • 9.Who are the key players/companies in the global endoscopic retrograde cholangiopancreatography market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endoscopic Retrograde Cholangiopancreatography Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Endoscope
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Endotherapy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Sphincterotomes
      • 6.2.2.2 Lithotripter
      • 6.2.2.3 Stents
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast
  • 6.3 Visualization Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Energy Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 Biliary Sphincterotomy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biliary Stenting
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biliary Dilatation
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pancreatic Sphincterotomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Pancreatic Duct Stenting
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pancreatic Duct Dilatation
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boston Scientific Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 CONMED Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cook Group Incorporated
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fujifilm Holdings Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hobbs Medical Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medi-Globe GmbH
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Olympus Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Shaili Endoscopy
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Steris Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Telemed Systems Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Major Drivers and Challenges
  • Figure 2: Global: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Procedure (in %), 2024
  • Figure 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: North America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: North America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: United States: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: United States: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Canada: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Canada: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: China: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: China: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Japan: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Japan: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: India: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: India: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: South Korea: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: South Korea: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Australia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Australia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Europe: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Europe: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Germany: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Germany: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: France: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: France: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Italy: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Italy: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Spain: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Spain: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Russia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Russia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Country (in %), 2024
  • Figure 84: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Endoscopic Retrograde Cholangiopancreatography Industry: SWOT Analysis
  • Figure 86: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Value Chain Analysis
  • Figure 87: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
  • Table 4: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Competitive Structure
  • Table 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Players